Business of Optometry

Top Story

Essilor, Luxottica merger progresses

March 24, 2017

Essilor’s board of directors signed the draft contribution agreements that relate to the transfer by Essilor International of substantially all of its activities and shareholders to its fully owned subsidiary, Delamare Sovra, to be renamed Essilor International.

In addition, Delfin will contribute all of its shares in Luxottica in exchange for new shares issued by Essilor, based on an exchange ratio of 0.461 Essilor share for one Luxottica share, according to an Essilor press release.

Second Sight posts $33.2 million net loss in 2016

March 24, 2017
Second Sight Medical Products reported a net loss of $33.2 million, or $0.84 per share, in 2016 compared with a net loss of $20 million, or $0.56 per share, the previous…

Nemus, Nanomerics to develop ocular formulation for glaucoma treatment

March 24, 2017
Nemus Bioscience and Nanomerics have signed a development agreement to develop a topical ocular formulation of tetrahydracannabinol-valine-hemisuccinate, according to a…

STAAR Surgical reports $12.1 million loss in 2016

March 24, 2017
STAAR Surgical reported a net loss of $12.1 million, or $0.30 per share, in 2016 compared with a net loss of $6.5 million, or $0.17 per share, in 2015, according to a…
COPE

Diabetic Eye Disease: Screening Strategies and Imaging Devices - Number 1

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Video
Meeting News

VIDEO: CEO discusses 2017 plans for Imprimis

January 14, 2017
More »
Featured
SECO

SECO

Video
Meeting News

VIDEO: OWL leader welcomes Hawaiian Eye attendees

January 14, 2017
More »

Essilor, Luxottica merger progresses

March 24, 2017
Essilor’s board of directors signed the draft contribution agreements that relate to the transfer by Essilor International of substantially all…

Second Sight posts $33.2 million net loss in 2016

March 24, 2017
Second Sight Medical Products reported a net loss of $33.2 million, or $0.84 per share, in 2016 compared with a net loss of $20 million, or $0.56 per…

Nemus, Nanomerics to develop ocular formulation for glaucoma treatment

March 24, 2017
Nemus Bioscience and Nanomerics have signed a development agreement to develop a topical ocular formulation of…

STAAR Surgical reports $12.1 million loss in 2016

March 24, 2017
STAAR Surgical reported a net loss of $12.1 million, or $0.30 per share, in 2016 compared with a net loss of $6.5 million, or $0.17 per share, in…

AGTC reports $2.1 million income in second quarter

March 23, 2017
Applied Genetic Technologies Corporation reported a net income of $2.1 million in its second fiscal quarter compared with a net income of $3 million…

ONL Therapeutics receives approximately $1 million grant from NEI

March 23, 2017
The National Eye Institute has awarded ONL Therapeutics a grant worth almost $1 million to continue developing its lead therapeutic candidate…

Restasis Multidose now available in US

March 22, 2017
Restasis Multidose, the first preservative-free prescription eye drop to be offered in a multidose bottle, is now available in the United States…

Novaliq, AFT Pharmaceuticals enter licensing agreement for NovaTears

March 21, 2017
Novaliq and AFT Pharmaceuticals have entered a strategic licensing agreement for the commercialization of Novaliq’s NovaTears in Australia and…

FDA sets Aug. 24 as PDUFA date for latanoprostene bunod

March 21, 2017
The FDA has set Aug. 24 for its decision on the new drug application for latanoprostene bunod, according to a press release from Bausch + Lomb and…

Visioneering Technologies raises $33 million, expands infrastructure

March 21, 2017
Visioneering Technologies Inc., manufacturer of the NaturalVue Multifocal 1 Day contact lenses, has raised $33.3 million following the close of its…

More Headlines »
Advertisement
Advertisement